The 20 references in paper V. Dobronravov A., S. Lapin V., N. Lazareva M., V. Sipovskyi G., I. Trofimenko I., A. Kisina A., V. Titova A., E. Saganova S., A. Smirnov V., В. Добронравов А., С. Лапин В., Н. Лазарева М., В. Сиповский Г., И. Трофименко И., А. Кисина А., В. Титова А., Е. Саганова С., А. Смирнов В. (2012) “ЦИРКУЛИРУЮЩИЕ АНТИТЕЛА К РЕЦЕПТОРУ ФОСФОЛИПАЗЫ А2 ПРИ ПЕРВИЧНОЙ МЕМБРАНОЗНОЙ НЕФРОПАТИИ // CIRCULATING PHOSPHOLIPASE A2 RECEPTOR ANTIBODIES IN PRIMARY MEMBRANOUS NEPHROPATHY” / spz:neicon:nefr:y:2012:i:4:p:39-44

1
Beck LH Jr, Bonegio RG, Lambeau G. et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361: 11–21
(check this in PDF content)
2
Stanescu HC, Arcos-Burgos M, Medlar A. et al. Risk HLADQA1 and PLA2R1 alleles in idiopathic membranous nephropathy. N Engl J Med 2011;364: 616–626
(check this in PDF content)
3
Debiec H, Ronco P. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med 2011; 364: 689–690
(check this in PDF content)
4
Kerjaschki D, Farquhar MG. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats. J Exp Med 1983; 157: 667–686
(check this in PDF content)
5
Qin W, Beck LH Jr, Zeng C. et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 2011;22(6):1137-1143
(check this in PDF content)
6
Hofstra JM, Beck LH Jr, Beck DM. et al. Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 2011; 6: 1286–1291
(check this in PDF content)
7
Beck LH, Fervenza FC, Beck DM. et al. Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol 2011;22: 1543–1550
(check this in PDF content)
8
Passerini P, Ponticelli C. Membranous nephropathy. In: Ponticelli C, Glassock R (eds). Treatment of Primary Glomerulonephritis, 2nd edn. Oxford University Press: Oxford, UK, 2009, pp 261–312
(check this in PDF content)
9
Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150: 604–612
(check this in PDF content)
10
Смирнов АВ. Лечение гломерулопатий циклоспорином: правильный подход с неверным обоснованием. Нефрология 2010; 14(4):9-22
(check this in PDF content)
11
ha V, Ganguli A, Saha TK et al. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. J Am Soc Nephrol 2007; 18:1899–1904
(check this in PDF content)
12
Remuzzi G, Chiurchiu C, Abbate M. et al. Rituximab for idiopathic membranous nephropathy. Lancet 2002;360: 923–924
(check this in PDF content)
13
Ruggenenti P, Chiurchiu C, Brusegan V. et al. Rituximab in idiopathic membranous nephropathy: A one-year prospective study. J Am Soc Nephrol 2003;14: 1851–1857
(check this in PDF content)
14
Bomback AS, Derebail VK, McGregor JG. et al. Rituximab therapy for membranous nephropathy: A systematic review. Clin J Am Soc Nephrol 2009; 4: 734–744
(check this in PDF content)
15
Fervenza FC, Cosio FG, Erickson SB. et al. Rituximab treatment of idiopathic membranous nephropathy. Kidney Int 2008; 73: 117–125
(check this in PDF content)
16
Cravedi P, Sghirlanzoni MC, Marasa M. et al. Efficacy and safety of rituximab second-line therapy for membranous nephropathy: A prospective, matched-cohort study. Am J Nephrol 2011; 33: 461–468
(check this in PDF content)
17
Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Int Suppl 2012; 2(2): 139–274
(check this in PDF content)
18
Segarra A, Praga M, Ramos N. et al. Successful treatment of membranous glomerulonephritis with rituximab in calcineurin inhibitor-dependent patients. Clin J Am Soc Nephrol 2009; 4: 1083–1088
(check this in PDF content)
19
Murtas C, Bruschi M, Candiano G. et al. Coexistence of Different Circulating Anti-Podocyte Antibodies in Membranous Nephropathy. Clin J Am Soc Nephrol 2012;7(9):1394-1400
(check this in PDF content)
20
Debiec H, Ronco P. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med 2011; 364: 689–690 Поступила в редакцию 25.09.2012 г. Принята в печать 11.10.2012 г.
(check this in PDF content)